Toxic shock-like syndrome;Streptococcal toxic shock-like syndrome

Chirurg

Volumn 69, Issue 8, 1998, Pages 806-812

  Broll, R ^a   Eckmann, C ^a   Kujath, P ^a   Bruch, H P ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

M proteins; Streptococcal pyrogenic endotoxins; Streptococcal toxic shock like syndrome; Streptococcus pyogenes

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CARRIER PROTEIN; ERYTHROGENIC TOXIN; EXOTOXIN; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; SPEA PROTEIN, STREPTOCOCCUS PYOGENES; STREPTOCOCCAL M PROTEIN;

ADULT; AGED; BLOOD; DRUG COMBINATION; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NECROTIZING FASCIITIS; PATHOGENICITY; REVIEW; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; VIRULENCE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; EXOTOXINS; FASCIITIS, NECROTIZING; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

EID: 0032138137     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050494     Document Type: Article

References (41)

1. Bartter T, Dascal A, Caroll K, Curley FJ (1988) Toxic strep syndrome. A manifestation of group A streptococcal infection. Arch Intern Med 148: 1421
2. Betley MJ, Borst DW, Regassa LB (1992) Staphylococcal enterotoxins, toxic shock syndrome toxin, and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem Immunol 55: 1
3. Bisno AL, Stevens DL (1996) Streptococcal infections of skin and soft tissues. N Engl J Med 334: 240
4. Brown DR, Noelle LD, Lepawsky M, Cunningham J, Kortbeek J (1994) A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 167: 485
5. Chomarat M, Chapuis C, Lepape A, Bernard F (1990) Two cases of severe infection with beta-haemolytic group A streptococci associated with a toxic-shock-like syndrome. Eur J Clin Microbiol Infect Dis 9: 901
6. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, et al (1992) Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339: 518
7. Gaworzewska E, Colman G (1988) Changes in the pattern of infection caused by streptococcus pyogenes. Epidemiol Infect 100: 257
8. Gemmell CG, Peterson PK, Schmeling D, Kim Y, et al (1981) Potentiation of opsonization and phagocytosis of streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest 67: 1249
9. Hackett SP, Stevens DL (1992) Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 165: 879
10. Hackett SP, Stevens DL (1993) Superantigens associated with Staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β synthesis. J Infect Dis 168: 232
11. Hasty DL, Ofek I, Courtney HS, Doyle RJ (1992) Multiple adhesins of streptococci. Infect Immun 60: 2147
12. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM (1991) Molecular analysis of pyrogenic exotoxins from streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 29: 1562
13. Henderson B, Poole S, Wilson M (1996) Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60: 316
14. Hoge CW, Schwartz B; Talkington DF, Breiman RF, et al (1993) The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269: 384
15. Holm SE, Norrby A, Bergholm AM, Norgren M (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 166: 31
16. Kappler J, Kotzin B, Herron L, Gelfand EW, et al (1989) Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 244: 811
17. Kotb M (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8: 411
18. Kujath P, Eckmann C, Benecke P (1995) Diagnose und Therapie der nekrotisierenden Fasziitis. Dtsch Med Wochenschr 120: 965
19. Kujath P, Eckmann C (1996) Hyperbare Oxygenation als ergänzende Therapieform der nekrotisierenden Fasziitis. Dtsch Med Wochenschr 121: 117
20. Kujath P, Eckmann C, Benecke P (1996) Die standardisierte Behandlung der nekrotisierenden Fasziitis. Zentralbl Chir 121: 35
21. Lancefield RC (1962) Current knowledge of type-specific M-antigens of group A streptococci. J Immunol 89: 307
22. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248: 705
23. Martin PR, Hoiby EA (1990) Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 22: 421
24. Norrby-Teglund A, Newton D, Kotb M, Holm SE, Norgren M (1994) Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun 62: 5227
25. Perez-Casal JF, Dillon HF, Husmann LK, Graham B, Scott JR (1993) Virulence of two streptococcus pyogenes strains (types M1 and M3) associated with toxic-shock-like syndrome depends on an intact mry-like gene. Infect Immun 61: 5426
26. Podbielski A, Rozdzinski E, Wiedeck H, Lütticken R (1997) Gruppe-A-Streptokokken und die nekrotisierende Fasziitis. Dt Arztebl 95: B-353
27. Quinn RW (1982) Epidemiology of group A streptococcal infections - their changing frequency and severity. Yale J Biol Med 55: 265
28. Reda KB, Kapur V, Mollick JA, Lamphear JG, et al (1994) Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from streptococcus pyogenes. Infect Immun 62: 1867
29. Riseman JA, Zamboni WA, Curtis A, Graham DR, et al (1990) Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 108: 847
30. Schwartz B, Facklam RR, Breiman RF (1990) Changing epidemiology of group A streptococcal infection in the USA. Lancet 336: 1167
31. Shanley TP, Schrier D, Kapur V, Kehoe M, et al (1996) Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun 64: 870
32. Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14: 2
33. Stevens DL, Maier KA, Mitten JE (1987) Effect of antibiotics on toxin production and viability of clostridium perfringens. Antimicrob Agents Chemother 31: 213
34. Stevens DL, Tanner MH, Winship J, Swarts R, et al (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1
35. Strömberg A, Romanus V, Burman LG (1991) Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 164: 595
36. The Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. JAMA 169: 390
37. Todd J, Fishaut M (1978) Toxic-shock-syndrome associated with phage-group-I staphylococci. Lancet II: 1116
38. Valenzuela TD, Hooton TM, Kaplan EL, Schlievert P (1991) Transmission of 'toxic strep' syndrome from an infected child to a firefighter during CPR. Ann Emerg Med 20: 123
39. Willis S, Schippers E, Schumpelick V (1997) Das "streptococcal toxic shock-like syndrome" als seltenes chirurgisches Krankheitsbild. Chirurg 68: 40
40. Willoughby R, Greenberg RN (1983) The toxic shock syndrome and streptococcal pyrogenic exotoxins. Ann Intern Med 98: 559
41. Wood TF, Potter MA, Jonasson O (1993) Streptococcal toxic shock-like syndrome. The importance of surgical intervention. Ann Surg 217: 109